Assoc. Prof. Yonca Yılmaz Ürün

1. Activity and Structure Analysis of Highly Functional Ru-Pt-Ni/AC Nanocatalysts for Efficient Glucose Electrooxidation

Ulaş B., Yılmaz Y., DEMİR KIVRAK H., Najri B. A., Erünal E.

Electrocatalysis , vol.17, no.1, pp.73-83, 2026 (SCI-Expanded, Scopus)

2. Prognostic significance of the Borrmann classification in stage 2-3 gastric cancer.

Cesur S., Ürün Y.

Saudi medical journal , vol.46, no.11, pp.1365-1370, 2025 (SCI-Expanded, Scopus)

3. Comparison of Doublet and Triplet Chemotherapy Regimens in Geriatric Patients with Metastatic Gastric Cancer

YILMAZ ÜRÜN Y., DİRİK Y., DÜZEN OFLAS N., GÜNER G., CESUR S., ÜRÜN M.

Eskisehir Medical Journal, Eskisehir City Hospital , vol.6, no.2, pp.75-80, 2025 (TRDizin)

4. Vitamin D Deficiency and Supplementation in Irritable Bowel Syndrome: Retrospective Evaluation of Subtype and Sex-Based Differences

Düzen Oflas N., Yılmaz Ürün Y.

Medicina (Lithuania) , vol.61, no.7, 2025 (SCI-Expanded, Scopus)

5. Vincamine Mitigates Methotrexate-Induced Liver Fibrosis Model.

Ürün Y., Güner G., Bora E. S., Taşkın A. B., Ürün M., Erbaş O.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.36, no.10, pp.641-648, 2025 (SCI-Expanded, Scopus, TRDizin)

6. Long-Term Impact of COVID-19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities

Marasco G., Hod K., Colecchia L., Cremon C., Barbaro M. R., Cacciari G., et al.

United European Gastroenterology Journal , vol.13, no.5, pp.798-818, 2025 (SCI-Expanded, Scopus)

7. Evaluation of second-line treatment options in metastatic esophageal squamous cell carcinoma

YILMAZ ÜRÜN Y., ÜRÜN M.

Journal of Current Hematology & Oncology Research , vol.3, no.2, pp.27-31, 2025 (Peer-Reviewed Journal)

8. Inflammatory Biomarkers from Blood Counts as Prognostic Tools in Metastatic Esophageal Cancer.

Ürün Y., Beypinar I.

Medical science monitor : international medical journal of experimental and clinical research , vol.31, 2025 (SCI-Expanded, Scopus)

9. Do Nutritional and Inflammatory Indices Predict Response in Geriatric Gastric Cancer Patients Treated with Neoadjuvant FLOT Regimen?

Ürün Y., Ürün M.

Cancer control : journal of the Moffitt Cancer Center , vol.32, 2025 (SCI-Expanded, Scopus)

10. Response: Do Nutritional and Inflammatory Indices Predict Response in Geriatric Gastric Cancer Patients Treated With Neoadjuvant FLOT Regimen?

Ürün Y., Ürün M.

Cancer control : journal of the Moffitt Cancer Center , vol.32, 2025 (SCI-Expanded, Scopus)

11. Psychological and Clinical Factors Mediate Post-COVID-19 Irritable Bowel Syndrome

Hod K., Marasco G., Colecchia L., Cremon C., Barbaro M. R., Cacciari G., et al.

Neurogastroenterology and Motility , 2025 (SCI-Expanded, Scopus)

12. Retrospective Analysis of Demographic, Clinical, Biochemical, and Histopathological Findings of Gastrointestinal Polyps

Sarı N. G., Elasan S., Altürk V., Ürün Y.

Van Medical Journal , vol.32, no.2, pp.70-79, 2025 (Scopus, TRDizin)

13. Capecitabine vs. 5-Fluorouracil: A Retrospective Study on Efficacy in Elderly Patients with Advanced Gastric Cancer

YILMAZ ÜRÜN Y., MERMİT ERÇEK B.

Eurasian Journal of Medical Investigation , vol.8, no.4, pp.238-244, 2024 (TRDizin)

14. Highly active polyethylene glycol grafted cellulose supported Pd nanoparticles for glucose electrooxidation

Ulaş B., Yilmaz Y., GÖK Ö., DEMİR KIVRAK H.

Process Safety and Environmental Protection , vol.185, pp.772-781, 2024 (SCI-Expanded, Scopus)

15. Highly efficient metal free aldehyde-functionalized indoles for direct glucose fuel cell anode catalyst

Çalış Karatekin H., Ulaş B., Yilmaz Y., DEMİR KIVRAK H., KIVRAK A.

International Journal of Hydrogen Energy , vol.63, pp.635-644, 2024 (SCI-Expanded, Scopus)

16. Comparison of the Efficacy of FOLFIRI and Paclitaxel Chemotherapy Regimens in the Second Line Treatment of Metastatic Gastric Cancer

ÜRÜN M., GÜNER G., SEZGİN Y., YILMAZ ÜRÜN Y., SAKİN A.

Van Yuzuncu Yil University , vol.16, no.2, pp.176-182, 2023 (Peer-Reviewed Journal)

17. ADDITIONAL COST OF OVERWEIGHT IN MEDICATION OF CANCER PATIENTS

ÜRÜN M., SEZGİN Y., YILMAZ ÜRÜN Y., UÇAN A., GÜRCÜ S., TUĞRUL F.

Eskisehir Medical Journal, Eskisehir City Hospital , vol.4, no.2, pp.107-110, 2023 (Peer-Reviewed Journal)

18. Post COVID-19 irritable bowel syndrome

Marasco G., Cremon C., Barbaro M. R., Cacciari G., Falangone F., Kagramanova A., et al.

Gut , vol.72, no.3, pp.484-492, 2023 (SCI-Expanded, Scopus)

19. The effects of proton pump inhibitors on the development of post-stenting major adverse cardiovascular events in patients with acute coronary syndrome

ÜNAL Y. O., GÖK SARGIN S. Z., YILMAZ ÜRÜN Y., KALAYCI B., ÜSTÜNDAĞ Y.

Medicine Science , vol.12, no.2, pp.522-526, 2023 (TRDizin)

20. Chemotherapy Efficacy and Tolerability in Metastatic Gastric Cancer Patients Aged 75 Years and Older

SEZGİN Y., YILMAZ ÜRÜN Y.

Eurasian Journal of Medical Investigation , vol.7, no.4, pp.487-493, 2023 (TRDizin)

21. The Comparison of FLOT vs. mDCF Regimens in Neoadjuvant Setting for Locally-advanced Gastric Cancer

ÜRÜN M., ŞAHİN S., YILMAZ ÜRÜN Y., SAKİN A.

Eurasian Journal of Medical Investigation , vol.7, no.3, pp.274-282, 2023 (TRDizin)

22. Development of Effective Bimetallic Electrocatalysts for Glucose Electrooxidation

Ulaş B., Yılmaz Ürün Y., DEMİR KIVRAK H., ERÜNAL E.

JOURNAL OF THE ELECTROCHEMICAL SOCIETY , vol.169, no.10, 2022 (SCI-Expanded, Scopus)

23. Too Rare Association; Fundal Diverticulum And Small Bowel Adenocarcinoma

YILMAZ ÜRÜN Y., AKAR T.

Eskisehir Medical Journal, Eskisehir City Hospital , vol.3, no.2, pp.257-258, 2022 (Peer-Reviewed Journal)

24. Hepatobiliary System Effects And Clinical Features of Sars-Cov-2 Infection; Case-Control Study

YALINBAŞ KAYA B., YILMAZ ÜRÜN Y., YENİLMEZ İ., MERT KANTAR Y., TÜREYEN A., HAMARAT H., et al.

Eskisehir Medical Journal, Eskisehir City Hospital , vol.3, no.2, pp.157-166, 2022 (Peer-Reviewed Journal)

25. Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study.

Marasco G., Cremon C., Barbaro M. R., Salvi D., Cacciari G., Kagramanova A., et al.

The American journal of gastroenterology , vol.117, no.1, pp.147-157, 2022 (SCI-Expanded, Scopus)

26. Clinical and Radiological Characteristics of COVID-19 Patients: A Single Center Experience in Eskişehir

ÇERÇİ P., BAYAV M., AKARSU M., AKGÜN H., yurdasiper a., ÖZDEMİR K., et al.

Eskisehir Medical Journal, Eskisehir City Hospital , vol.2, no.3, pp.194-205, 2021 (Peer-Reviewed Journal)

27. Standardized versus nonstandardized pharmacologic treatment for hepatorenal syndrome

Ustundag Y., KARASU A. Z., Urun Y.

European Journal of Gastroenterology and Hepatology , vol.33, no.10, pp.1334-1335, 2021 (SCI-Expanded, Scopus)

28. The Effects of Insulin Therapy on Fetuin-A Levels in Type-2 Diabetic Patients

ÜRÜN M., YILMAZ ÜRÜN Y., SAHİP B., ŞENTOSUN U.

Medical Journal of Western Black Sea , vol.4, 2020 (TRDizin)

29. Evaluation of galectin-3 in patients with heart failure and its relationship with NT-proBNP levels: A case-control study

YILMAZ ÜRÜN Y., ÖZDEMİR M., ASOĞLU R., yiğit n.

Journal of Surgery and Medicine , vol.4, no.2, 2020 (Peer-Reviewed Journal)

30. Factors affecting survival in esophageal squamous cell carcinoma: Single-center experience

Sakin A., Urun Y., Sahin S., Atici M. M., Arici S., Geredeli C., et al.

NORTHERN CLINICS OF ISTANBUL , vol.7, no.3, pp.267-274, 2020 (ESCI, TRDizin) Sustainable Development

31. Single dose aspirin affects fecal immunohistochemical test sensitivity in detecting advanced colorectal neoplasms: Truth or expectation?

Ürün Y., Aydemir S.

Turkish Journal of Gastroenterology , vol.31, no.1, pp.80-82, 2020 (SCI-Expanded, Scopus, TRDizin)

32. Post-colonoscopy colorectal cancer rates in the Swedish IBD and non-IBD population: Something missed or something faster?

Ürün Y., Üstündaǧ Y.

Turkish Journal of Gastroenterology , vol.30, no.9, pp.860-862, 2019 (SCI-Expanded, Scopus, TRDizin)

33. Bile duct fascioliasis

ÜSTÜNDAĞ Y., YILMAZ ÜRÜN Y.

VideoGIE , vol.3, no.3, pp.89-90, 2018 (Scopus)

34. Metabolik Sendromlu Hastalarda İnsülin Direnciyle Doku Faktör Yolu İnhibitörü (TFPI) Arasındaki İlişki

OMMA T., YILMAZ ÜRÜN Y., yiğit n., ÜRÜN M., KOLDAŞ M., ulusoy m., et al.

Smyrna Tıp Dergisi , 2014 (Peer-Reviewed Journal)

Publications & Works